SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1479.95 millions.Net Profit for the quarter ended June 2025 dipped to Rs. 81.19  millions from Rs. 344.26 millions  in the corresponding previous quarter.The company reported a degrowth in operating Profit to 176.53 millions from 417.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1479.95 1443.07 2.56 1479.95 1443.07 2.56 5496.47 16725.66 -67.14
Other Income 145.82 430.70 -66.14 145.82 430.70 -66.14 812.75 882.95 -7.95
PBIDT 176.53 417.96 -57.76 176.53 417.96 -57.76 683.35 3871.13 -82.35
Interest 11.51 97.12 -88.15 11.51 97.12 -88.15 29.18 1037.67 -97.19
PBDT 165.02 400.45 -58.79 165.02 400.45 -58.79 2886.21 6743.44 -57.20
Depreciation 66.77 56.19 18.83 66.77 56.19 18.83 244.79 804.10 -69.56
PBT 98.25 344.26 -71.46 98.25 344.26 -71.46 2641.42 5939.34 -55.53
TAX 17.06 0.00 0.00 17.06 0.00 0.00 80.58 577.55 -86.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -38.26 -108.43 -64.71
PAT 81.19 344.26 -76.42 81.19 344.26 -76.42 2560.84 5361.79 -52.24
Equity 687.44 672.12 2.28 687.44 672.12 2.28 687.44 672.12 2.28
PBIDTM(%) 11.93 28.96 -58.82 11.93 28.96 -58.82 12.43 23.14 -46.28

Ind-Swift Lab. Share Price

143.15 7.20 (5.30%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×